JP2006521407A5 - - Google Patents

Download PDF

Info

Publication number
JP2006521407A5
JP2006521407A5 JP2006509430A JP2006509430A JP2006521407A5 JP 2006521407 A5 JP2006521407 A5 JP 2006521407A5 JP 2006509430 A JP2006509430 A JP 2006509430A JP 2006509430 A JP2006509430 A JP 2006509430A JP 2006521407 A5 JP2006521407 A5 JP 2006521407A5
Authority
JP
Japan
Prior art keywords
aryl
compound
hydrogen
heteroaryl
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006509430A
Other languages
English (en)
Japanese (ja)
Other versions
JP4928937B2 (ja
JP2006521407A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/009571 external-priority patent/WO2004087673A2/en
Publication of JP2006521407A publication Critical patent/JP2006521407A/ja
Publication of JP2006521407A5 publication Critical patent/JP2006521407A5/ja
Application granted granted Critical
Publication of JP4928937B2 publication Critical patent/JP4928937B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006509430A 2003-03-28 2004-03-26 ミグラスタチンアナログおよびその使用 Expired - Fee Related JP4928937B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45882703P 2003-03-28 2003-03-28
US60/458,827 2003-03-28
US49616503P 2003-08-19 2003-08-19
US60/496,165 2003-08-19
PCT/US2004/009571 WO2004087673A2 (en) 2003-03-28 2004-03-26 Migrastatin analogs and uses thereof

Publications (3)

Publication Number Publication Date
JP2006521407A JP2006521407A (ja) 2006-09-21
JP2006521407A5 true JP2006521407A5 (cg-RX-API-DMAC10.html) 2007-06-07
JP4928937B2 JP4928937B2 (ja) 2012-05-09

Family

ID=33135114

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006509369A Expired - Fee Related JP4719671B2 (ja) 2003-03-28 2004-03-26 ミグラスタチンアナログ組成物およびその使用
JP2006509430A Expired - Fee Related JP4928937B2 (ja) 2003-03-28 2004-03-26 ミグラスタチンアナログおよびその使用
JP2011039073A Withdrawn JP2011105766A (ja) 2003-03-28 2011-02-24 ミグラスタチンアナログ組成物およびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006509369A Expired - Fee Related JP4719671B2 (ja) 2003-03-28 2004-03-26 ミグラスタチンアナログ組成物およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011039073A Withdrawn JP2011105766A (ja) 2003-03-28 2011-02-24 ミグラスタチンアナログ組成物およびその使用

Country Status (5)

Country Link
US (4) US7943800B2 (cg-RX-API-DMAC10.html)
EP (2) EP1613603A2 (cg-RX-API-DMAC10.html)
JP (3) JP4719671B2 (cg-RX-API-DMAC10.html)
CA (2) CA2520377A1 (cg-RX-API-DMAC10.html)
WO (2) WO2004087672A1 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070037783A1 (en) * 2003-03-28 2007-02-15 Xin-Yun Huang Migrastatin analogs and uses thereof
JP4719671B2 (ja) 2003-03-28 2011-07-06 コーネル・リサーチ・ファンデーション・インコーポレイテッド ミグラスタチンアナログ組成物およびその使用
US8957056B2 (en) 2004-05-25 2015-02-17 Sloan-Kettering Instiute For Cancer Research Migrastatin analogs in the treatment of cancer
WO2006000923A2 (en) * 2004-06-03 2006-01-05 Novimmune Sa Macrolide compositions as therapeutic agent
US8188141B2 (en) 2004-09-23 2012-05-29 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
EP2170827B1 (en) * 2007-06-21 2013-08-14 Janssen Pharmaceutica, N.V. Indolin-2-ones and aza-indolin-2-ones
WO2009110938A2 (en) * 2007-12-10 2009-09-11 Novobiotic Pharmaceuticals Llc Novel macrocyclic polyene lactams
CN102076339A (zh) * 2008-04-24 2011-05-25 百时美施贵宝公司 埃坡霉素D在治疗包括阿尔茨海默病的τ相关疾病中的用途
AU2012239977B9 (en) 2011-04-07 2016-11-17 Sloan-Kettering Institute For Cancer Research Migrastatins and uses thereof
WO2013013240A2 (en) * 2011-07-21 2013-01-24 Theracrine, Inc. Macrocyclic compounds and related compositons and methods of use
CN108218932B (zh) * 2017-12-27 2019-01-04 北京大学 凝集素受体介导的癌症预靶向治疗药物
US11187655B2 (en) 2018-05-16 2021-11-30 Sensera, Inc. Compact gas sensors

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL66434C (cg-RX-API-DMAC10.html) * 1946-12-06
FR1264032A (fr) 1960-05-06 1961-06-19 Rhone Poulenc Sa Acide cycloundecanecarboxylique
GB1036084A (en) * 1962-02-23 1966-07-13 Upjohn Co Oxygenated cycloalkanes and the preparation thereof
NL302921A (cg-RX-API-DMAC10.html) 1963-01-21
DE2934683A1 (de) 1979-08-28 1981-03-12 Haarmann & Reimer Gmbh, 3450 Holzminden 3-methyl-cyclohexadecen-5-on-1, verfahren zu seiner herstellung und seine verwendung als riechstoff.
DE2934678A1 (de) 1979-08-28 1981-03-12 Haarmann & Reimer Gmbh, 3450 Holzminden Cyclopentadecen-8-on-1, verfahren zu seiner herstellung und seine verwendung als riechstoff
US4472435A (en) 1980-07-31 1984-09-18 Hoffman-La Roche Inc. Benzophenone derivatives useful in treating heart failure
JPS6156146A (ja) 1984-08-28 1986-03-20 Nippon Mining Co Ltd 大環状ケトンの製造方法
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
EP0374445A1 (fr) 1988-12-23 1990-06-27 Firmenich Sa Nouveaux composés cycliques oxygénés, leur utilisation à titre d'ingrédients parfumants, procédé pour leur préparation
JPH07138257A (ja) 1993-11-16 1995-05-30 Taisho Pharmaceut Co Ltd 骨吸収抑制物質br−040及びbr−042
AR043071A1 (es) 1997-10-31 2005-07-20 Abbott Lab Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica
EP0976714A1 (en) 1998-07-06 2000-02-02 Quest International B.V. Addition of ketones to alkenes
SG80643A1 (en) 1998-09-03 2001-05-22 Givaudan Roure Int Methylcyclotetradec-5-en-1-ones
JP2000247949A (ja) 1999-02-26 2000-09-12 Eisai Co Ltd スルホンアミド含有インドール化合物
JP2001078793A (ja) 1999-09-10 2001-03-27 Nippon Kayaku Co Ltd 新規生理活性物質の醗酵法による製造法
JP2001081088A (ja) 1999-09-10 2001-03-27 Nippon Kayaku Co Ltd 新規生理活性物質nk30424類縁体とそれらの製造法および用途
WO2001046451A1 (en) 1999-12-22 2001-06-28 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Migrastatin, process for producing the same and medicinal compositions
US6750047B2 (en) * 2000-08-21 2004-06-15 Kosan Biosciences, Inc. Fermentation and purification of migrastatin and analog
US6660306B2 (en) 2000-10-12 2003-12-09 Mickey L. Peshoff Wound healing compound
TWI312681B (en) 2001-02-01 2009-08-01 Novel physiologically active substance
AU2002254822A1 (en) 2001-04-26 2002-11-11 Ecopia Biosciences Inc. Genes and proteins for the biosynthesis of polyketides
DE60216362T2 (de) * 2001-06-08 2007-09-20 Takasago International Corp. Inhibitoren der Melaninherstellung und solche Inhibitoren enthaltende Hautpflegemittel
JP2003104967A (ja) 2001-09-28 2003-04-09 Takuma Sasaki ウロキナーゼ産生阻害剤、血管新生阻害剤、癌転移抑制剤および抗腫瘍剤
JP3973889B2 (ja) 2001-12-04 2007-09-12 株式会社ジャパンエナジー 大環状ケトン化合物の製造方法
JP4463682B2 (ja) 2002-07-23 2010-05-19 ソシエテ ド テクノロジー ミシュラン 補強構造体の非真直アンカーリングを備えたタイヤ
KR20050084224A (ko) 2002-12-09 2005-08-26 더 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 야누스 티로신 키나제 3을 선택적으로 저해하는 방법
JP4337815B2 (ja) 2003-03-19 2009-09-30 宇部興産株式会社 ω−シアノアルデヒド化合物の製造法
US20070037783A1 (en) 2003-03-28 2007-02-15 Xin-Yun Huang Migrastatin analogs and uses thereof
JP4719671B2 (ja) 2003-03-28 2011-07-06 コーネル・リサーチ・ファンデーション・インコーポレイテッド ミグラスタチンアナログ組成物およびその使用
WO2005019181A1 (en) 2003-08-19 2005-03-03 Cornell Research Foundation, Inc. Migrastatin analog cell migration inhibitors
US8957056B2 (en) 2004-05-25 2015-02-17 Sloan-Kettering Instiute For Cancer Research Migrastatin analogs in the treatment of cancer
US8188141B2 (en) 2004-09-23 2012-05-29 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
CN101918036A (zh) 2007-11-21 2010-12-15 康奈尔大学 抑制肌成束蛋白的方法
EP2348845A4 (en) 2008-10-15 2013-01-23 Infinity Pharmaceuticals Inc ANSAMYCIN HYDROQUINONE COMPOSITIONS

Similar Documents

Publication Publication Date Title
JP6885390B2 (ja) Axl阻害剤と免疫チェックポイント阻害剤とを組み合わせて投与することを特徴とする癌治療のための医薬
JP2021519783A5 (cg-RX-API-DMAC10.html)
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
JP2008500366A5 (cg-RX-API-DMAC10.html)
JP2008524328A5 (cg-RX-API-DMAC10.html)
IL312845B1 (en) Extacan derivatives, charge-linkers, and their conjugates
JP2011509309A5 (cg-RX-API-DMAC10.html)
JP2007505933A5 (cg-RX-API-DMAC10.html)
JP2012507522A5 (cg-RX-API-DMAC10.html)
JP2021534108A5 (cg-RX-API-DMAC10.html)
JP2021527125A5 (cg-RX-API-DMAC10.html)
JP2021534106A5 (cg-RX-API-DMAC10.html)
WO2005118612A1 (en) Cholesterol/bile acid/bile acid derivative-modified therapeutic anti-cancer drugs
ATE427949T1 (de) 4-a4-(5-oxo-2,3,5,11a-tetrahydro-5h-pyrrolo a2, 1-cua1,4ubenzodiazepin-8-yloxy)-butyrylaminou-1 - pyrrol-2-carbonsaurealkylesterderivate und verwandte verbindung zur behandlung einer proliferativen erkrankung
JP2002524463A5 (cg-RX-API-DMAC10.html)
JP2011518190A5 (cg-RX-API-DMAC10.html)
JP2008523099A5 (cg-RX-API-DMAC10.html)
JP2011507878A5 (cg-RX-API-DMAC10.html)
JP2010509284A5 (cg-RX-API-DMAC10.html)
JP2006507355A5 (cg-RX-API-DMAC10.html)
RU2018127728A (ru) Слитые трициклические гетероциклические соединения в качестве ингибиторов интегразы вич
JP2010533699A5 (cg-RX-API-DMAC10.html)
JP2010520884A5 (cg-RX-API-DMAC10.html)
JP2007529426A5 (cg-RX-API-DMAC10.html)
WO2014129495A1 (ja) 眼疾患処置薬